Science Applications International financials
$130.93−1.27%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '27 Jul 31 | Q1 '27 May 1 | Q4 '26 Jan 30 | Q3 '26 Oct 31 | Q2 '26 Aug 1 | Q1 '26 May 2 | Q4 '25 Jan 31 | Q3 '25 Nov 1 | Q2 '25 Aug 2 | Q1 '25 May 3 | Q4 '24 Feb 2 | Q3 '24 Nov 3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.88B | $1.91B | $1.75B | $1.87B | $1.77B | $1.88B | $1.84B | $1.98B | $1.82B | $1.85B | $1.74B | $1.90B |
| Gross profit | $239.0M | $249.0M | $221.0M | $227.0M | $215.0M | $209.0M | $232.0M | $237.0M | $210.0M | $213.0M | $192.0M | $229.0M |
| Gross margin | 12.7% | 13.1% | 12.6% | 12.2% | 12.2% | 11.1% | 12.6% | 12.0% | 11.6% | 11.5% | 11.1% | 12.1% |
| Operating income | $152.0M | $179.0M | $134.0M | $128.0M | $139.0M | $121.0M | $128.0M | $160.0M | $133.0M | $131.0M | $81.0M | $143.0M |
| Net income | $102.0M | $115.0M | $85.0M | $78.0M | $127.0M | $68.0M | $98.0M | $106.0M | $81.0M | $77.0M | $39.0M | $93.0M |
| Net margin | 5.4% | 6.0% | 4.9% | 4.2% | 7.2% | 3.6% | 5.3% | 5.4% | 4.5% | 4.2% | 2.2% | 4.9% |
| Diluted EPS | $2.38 | $2.61 | $1.88 | $1.69 | $2.71 | $1.42 | $2.00 | $2.13 | $1.58 | $1.48 | $0.74 | $1.76 |
| EBITDA | $191.0M | $219.0M | $174.0M | $166.0M | $174.0M | $157.0M | $164.0M | $195.0M | $167.0M | $166.0M | $79.0M | $177.0M |
| Operating cash flow | $146.0M | $127.0M | $258.0M | $129.0M | $122.0M | $100.0M | $115.0M | $143.0M | $138.0M | $98.0M | $63.0M | $101.0M |
| Free cash flow | $131.0M | $118.0M | $250.0M | $120.0M | $115.0M | $92.0M | $100.0M | $134.0M | $132.0M | $92.0M | $52.0M | $97.0M |
| Diluted shares | 42.8M | 44.0M | 45.3M | 46.1M | 46.8M | 47.8M | 48.9M | 49.8M | 51.2M | 52.1M | 52.8M | 53.3M |
Balance sheet
| Period end | Jul 31 | May 1 | Jan 30 | Oct 31 | Aug 1 | May 2 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $126.0M | $109.0M | $182.0M | $45.0M | $48.0M | $47.0M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.48B | $2.49B | $2.49B | $2.49B | $2.29B | $2.28B |
| Total assets | $5.42B | $5.34B | $5.35B | $5.42B | $5.20B | $5.21B |
| Total liabilities | $3.99B | $3.92B | $3.85B | $3.91B | $3.68B | $3.71B |
| Shareholders' equity | $1.44B | $1.42B | $1.50B | $1.51B | $1.52B | $1.50B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology